Revvity (NYSE:RVTY) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Revvity (NYSE:RVTY) from a hold rating to a buy rating in a report published on Saturday.

Several other analysts also recently issued reports on the stock. Zacks Research raised shares of Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Evercore reiterated an “outperform” rating on shares of Revvity in a report on Wednesday, August 5th. TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Wolfe Research began coverage on shares of Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Finally, Sanford C. Bernstein initiated coverage on shares of Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price on the stock. Three analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $108.36.

Revvity Stock Up 1.1%

Shares of NYSE:RVTY opened at $115.91 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. Revvity has a 52-week low of $81.22 and a 52-week high of $118.30. The business’s 50 day simple moving average is $108.31 and its two-hundred day simple moving average is $99.97. The firm has a market cap of $12.93 billion, a P/E ratio of 55.20, a PEG ratio of 2.09 and a beta of 1.07.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm had revenue of $711.00 million during the quarter, compared to the consensus estimate of $702.96 million. During the same quarter in the previous year, the company posted $1.18 earnings per share. The company’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, research analysts forecast that Revvity will post 5.35 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. Revvity’s dividend payout ratio is presently 13.33%.

Institutional Investors Weigh In On Revvity

Institutional investors have recently added to or reduced their stakes in the company. New Mexico Educational Retirement Board raised its stake in shares of Revvity by 1.9% in the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock valued at $524,000 after buying an additional 100 shares during the period. Allworth Financial LP grew its stake in shares of Revvity by 8.9% during the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock worth $123,000 after acquiring an additional 104 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Revvity by 17.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock worth $66,000 after acquiring an additional 109 shares during the last quarter. HighTower Advisors LLC increased its holdings in Revvity by 2.6% in the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock worth $497,000 after acquiring an additional 129 shares during the last quarter. Finally, Cary Street Partners Financial LLC raised its stake in Revvity by 1.6% in the 4th quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company’s stock valued at $865,000 after acquiring an additional 141 shares during the period. 86.65% of the stock is owned by institutional investors.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.